These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8731161)

  • 1. Locomotor sensitization to [D-Trp(11)]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats.
    Boulay D; Duterte-Boucher D; Nouel D; Costentin J
    Neurosci Lett; 1996 Apr; 208(1):5-8. PubMed ID: 8731161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locomotor effects of [D-Trp11]neurotensin and dopamine transmission in rats.
    Nouel D; Costentin J
    Eur J Pharmacol; 1994 Mar; 254(3):263-9. PubMed ID: 8013561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.
    Fredrickson P; Boules M; Yerbury S; Richelson E
    Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    Boulay D; Duterte-Boucher D; Leroux-Nicollet I; Naudon L; Costentin J
    J Pharmacol Exp Ther; 1996 Jul; 278(1):330-7. PubMed ID: 8764367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Place conditioning with cocaine and the dopamine uptake inhibitor GBR12783.
    Le Pen G; Duterte-Boucher D; Costentin J
    Neuroreport; 1996 Nov; 7(18):2839-42. PubMed ID: 9116192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin receptor activation sensitizes to the locomotor stimulant effect of cocaine: a role for NMDA receptors.
    Rompré PP; Bauco P
    Brain Res; 2006 Apr; 1085(1):77-86. PubMed ID: 16574078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization to the rewarding effects of the specific dopamine uptake inhibitor GBR12783.
    Le Pen G; Duterte-Boucher D; Costentin J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):688-96. PubMed ID: 9694922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated activation of neurotensin receptors sensitizes to the stimulant effect of amphetamine.
    Rompré PP
    Eur J Pharmacol; 1997 Jun; 328(2-3):131-4. PubMed ID: 9218694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation.
    Blackburn A; Dewar K; Bauco P; Rompré PP
    Brain Res; 2004 Feb; 998(2):184-93. PubMed ID: 14751589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P; Rompré PP
    Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization.
    Fredrickson P; Boules M; Yerbury S; Richelson E
    Brain Res; 2003 Jul; 979(1-2):245-8. PubMed ID: 12850594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    Acri JB; Siedleck BK; Witkin JM
    J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of behavioral sensitization to cocaine by NAALADase inhibition.
    Shippenberg TS; Rea W; Slusher BS
    Synapse; 2000 Nov; 38(2):161-6. PubMed ID: 11018790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
    Nouel D; Dubuc I; Kitabgi P; Costentin J
    Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of neurotensin-induced motor activity by inhibition of protein kinase.
    Kalivas PW
    Psychopharmacology (Berl); 1994 Feb; 114(1):175-80. PubMed ID: 7846201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of context in neurotensin-induced sensitization to the locomotor stimulant effect of amphetamine.
    Rouibi K; Rompré PP
    Peptides; 2014 Aug; 58():103-7. PubMed ID: 24969625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a role of endogenous neurotensin in the development of sensitization to the locomotor stimulant effect of morphine.
    Lévesque K; Lamarche C; Rompré PP
    Eur J Pharmacol; 2008 Oct; 594(1-3):132-8. PubMed ID: 18706409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated intravenous cocaine administration: locomotor activity and dopamine D2/D3 receptors.
    Wallace DR; Mactutus CF; Booze RM
    Synapse; 1996 Jul; 23(3):152-63. PubMed ID: 8807743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
    Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
    Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.